ACADIA Pharmaceuticals Stock (NASDAQ: ACAD) stock price, news, charts, stock research, profile.
Open | $18.200 |
Close | - |
Volume / Avg. | 15.961K / 1.848M |
Day Range | 18.180 - 18.300 |
52 Wk Range | 17.560 - 33.990 |
Market Cap | $3.007B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 27 |
Short Interest | 7.64% |
Days to Cover | 5.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ACADIA Pharmaceuticals (NASDAQ: ACAD) through any online brokerage.
Other companies in ACADIA Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX) and TG Therapeutics (NASDAQ:TGTX).
The latest price target for ACADIA Pharmaceuticals (NASDAQ: ACAD) was reported by JP Morgan on Monday, March 25, 2024. The analyst firm set a price target for 25.00 expecting ACAD to rise to within 12 months (a possible 37.25% upside). 62 analyst firms have reported ratings in the last year.
The stock price for ACADIA Pharmaceuticals (NASDAQ: ACAD) is $18.215 last updated Today at March 28, 2024 at 9:35 AM EDT.
There are no upcoming dividends for ACADIA Pharmaceuticals.
ACADIA Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for ACADIA Pharmaceuticals.
ACADIA Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.